CAMBRIDGE, Mass., Nov. 1, 2023
/PRNewswire/ -- Flagship Pioneering today launched Pioneering
Intelligence, an initiative of Flagship Pioneering harnessing
artificial intelligence (AI) to accelerate innovation in the life
sciences and beyond. Flagship marked the official launch of
Pioneering Intelligence with an AI Summit that drew tech and life
sciences leaders from around the globe for a day long series of
talks. Initiated in 2021, Pioneering Intelligence will augment the
capabilities of Flagship companies, drive AI and machine learning
(ML) innovation, and originate new platform companies built on AI
advances.
"Pioneering Intelligence is an increasingly important initiative
of Flagship charged with accelerating innovation across
our enterprise," said Noubar Afeyan,
Ph.D., Founder and CEO of Flagship Pioneering, at Flagship's AI
Summit. "By institutionalizing AI/ML knowledge across the ecosystem
while leveraging best-in-class ML capabilities, Pioneering
Intelligence not only brings value to our companies and
origination teams, but also positions Flagship as a leader and key
source for expertise and information exchange in the AI/ML
community."
Augmenting ecosystem companies
Across the Flagship ecosystem, dozens of companies are building
out AI-enabled platforms to transform drug discovery, speed up the
drug development process, and gain new insights into human health
and sustainability. Pioneering Intelligence is building unique
AI/ML know-how that will enhance and complement the
capabilities of AI-enabled platforms of Flagship companies.
"Flagship companies have been leveraging AI for many years, and
by centralizing our know-how and infrastructure through Pioneering
Intelligence, we can address unique challenges faced by our
companies as they develop solutions for patients and the planet, as
well as to solve foundational problems in biology, computation, and
beyond," said Armen Mkrtchyan,
Ph.D., Head of the Pioneering Intelligence Initiative at Flagship
Pioneering.
Driving breakthroughs
Flagship's unique emergent discovery process produces
first-of-their-kind platform companies that change the world. By
driving AI/ML innovation, Pioneering Intelligence will amplify the
process of creating breakthroughs and enhance Flagship's
origination process. The initiative has built AI-driven tools to
allow Flagship scientists and entrepreneurs to uncover emergent
insights from large-scale scientific literature datasets. The team
has also developed innovative ML models to tackle foundational
problems in biology and chemistry, such as designing novel
molecules and uncovering cellular and disease insights.
"With these newest AI tools, we can reimagine what it means to
be an entrepreneur," said Geoffrey von
Maltzahn, Ph.D., General Partner at Flagship Pioneering.
"There are many limitations in human cognition and intelligence
that don't apply to machines, and by using AI as a true co-pilot
during our exploration process we can surpass these limits and more
efficiently and effectively search for white space where new
platforms can make the biggest impact."
Building leading AI companies
As a leader in AI/ML innovation, Pioneering Intelligence will
also become a source for industry-leading AI-driven companies. The
initiative will focus on harnessing advances in computation
integrated with a wide range of scientific domains to originate new
companies. To date, Pioneering Intelligence has launched one new
platform company still in stealth.
"Over the last decade we have witnessed the evolution of AI/ML
and its impact across many areas in the life sciences and beyond,"
said Mkrtchyan. "We have built Pioneering Intelligence and its
dedicated team of computational scientists and engineers to
position ourselves at the forefront of this progress and to broaden
scope of company origination."
About Pioneering Intelligence
Pioneering Intelligence is an initiative of Flagship Pioneering
harnessing artificial intelligence (AI) to accelerate innovation in
the life sciences and beyond. Pioneering Intelligence is building
unique AI and machine learning know-how to augment the capabilities
of Flagship companies and enable bigger leaps in human health and
sustainability, amplify the process of creating breakthrough
innovations, and originate new platform companies that build on
innovations in machine learning. For more information, visit
www.flagshippioneering.com/pioneering-intelligence or follow us on
X (formerly Twitter) and LinkedIn.
About Flagship Pioneering
Flagship Pioneering is a biotechnology company that invents and
builds platform companies, each with the potential for multiple
products that transform human health or sustainability. Since its
launch in 2000, Flagship has originated and fostered more than 100
scientific ventures, resulting in more than $90 billion in aggregate value. To date, Flagship
has deployed over $3.4 billion in
capital toward the founding and growth of its pioneering companies
alongside more than $26 billion of
follow-on investments from other institutions. The current Flagship
ecosystem comprises 43 companies, including Denali
Therapeutics (NASDAQ: DNLI), Foghorn
Therapeutics (NASDAQ:
FHTX), Generate:Biomedicines, Inari, Indigo
Agriculture, Moderna (NASDAQ: MRNA), Omega
Therapeutics (NASDAQ: OMGA), Sana
Biotechnology (NASDAQ: SANA), Seres
Therapeutics (NASDAQ: MCRB) and Tessera Therapeutics.
Media Contact:
press@flagshippioneering.com
View original content to download
multimedia:https://www.prnewswire.com/news-releases/flagship-pioneering-launches-pioneering-intelligence-301973453.html
SOURCE Flagship Pioneering